IMS Health purchased for $5.2 billion

IMS Health will be acquired by TPG Capital and the Canadian Pension Plan Investment Board, an investment management organization, for $5.2 billion.

The acquisition also covers IMS Health's outstanding debt, equaling roughly $1.3 billion as of September 30, according to third quarter reports.

A spokesperson for IMS Health said the company will continue operating under its flagship name—IMS Health. There are no immediate plans to change senior management, the spokesperson said. IMS Health “will continue our focus on expanding into new markets, further improving the quality and depth of offerings we deliver to our clients and playing a bigger role in the healthcare market,” David Carlucci, IMS chairman and CEO, said in a statement. The acquisition is expected to be completed by the end of the first quarter, 2010.

IMS Health's third quarter revenue was $540.8 million—down from $573.7 during the same period last year.
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters

Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.